ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

Large Bowel Study Expansion Hampered By Lack Of Coordination, NCI Admits

May 17, 1974

NCI Ponders Options for Implementing NCAB Changes In Organ Site Program

June 4, 1982

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

March 31, 2000